Morgan Stanleys Strategic Reduction in Royalty Pharma PLC Holdings
| MSHLX Fund | USD 45.01 0.52 1.14% |
Slightly above 61% of Growth Portfolio's investor base is looking to short. The analysis of overall sentiment of trading Growth Portfolio Class mutual fund suggests that many investors are alarmed at this time. Growth Portfolio's investing sentiment can be driven by a variety of factors including economic data, Growth Portfolio's earnings reports, geopolitical events, and overall market trends.
Growth |
Overview of Morgan Stanleys Recent Transaction On September 30, 2024, Morgan Stanley executed a significant transaction involving the shares of Royalty Pharma
Read at gurufocus.com
 |
Growth Portfolio Fundamental Analysis
We analyze Growth Portfolio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Growth Portfolio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Growth Portfolio based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Growth Portfolio is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Growth Portfolio Class Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Growth Portfolio mutual fund to make a market-neutral strategy. Peer analysis of Growth Portfolio could also be used in its relative valuation, which is a method of valuing Growth Portfolio by comparing valuation metrics with similar companies.
Peers
Growth Portfolio Related Equities
| BSGSX | Baird Small/mid | 1.63 | ||||
| ANORX | Small Cap | 0.30 | ||||
| HSCYX | The Hartford | 0.38 | ||||
| AATSX | Ancora/thelen Small-mid | 0.44 | ||||
| VSTCX | Vanguard Strategic | 0.45 | ||||
| CIPNX | Champlain Small | 0.97 | ||||
| CWSIX | Chartwell Small | 0.99 |
Other Information on Investing in Growth Mutual Fund
Growth Portfolio financial ratios help investors to determine whether Growth Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Growth with respect to the benefits of owning Growth Portfolio security.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |